I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Peereboom, David
245
results:
Search for persons
X
Format
Online (245)
Mediatypes
Articles (Online) (173)
Bookchapter (Online) (8)
OpenAccess-fulltext (64)
Sorted by: Relevance
Sorted by: Year
?
1
Phase 1 dose expansion and biomarker study assessing first-..:
Chen, Jian Jenny
;
Vincent, Melanie Y.
;
Shepard, Dale
...
Communications Medicine. 4 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1038/..
?
2
IMMU-34. SYSTEMIC IMMUNE SUPPRESSION IN GLIOBLASTOMA IS TAR..:
Ozair, Ahmad
;
Alban, Tyler
;
Grabowski, Matthew
...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v149-v149 , 2023
Link:
https://doi.org/10.1093/..
?
3
CTNI-08. TUCATINIB, TRASTUZUMAB, AND CAPECITABINE WITH STER..:
Ahluwalia, Manmeet
;
Ozair, Ahmad
;
Khosla, Atulya
...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v74-v74 , 2023
Link:
https://doi.org/10.1093/..
?
4
CTIM-19. ONCOLYTIC DNX-2401 VIROTHERAPY PLUS PEMBROLIZUMAB ..:
Nassiri, Farshad
;
Patil, Vikas
;
Yefet, Leeor
...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v65-v66 , 2023
Link:
https://doi.org/10.1093/..
?
5
CTNI-21. PHASE I STUDY OF BTK INHIBITOR IBRUTINIB WITH TEMO..:
Ahluwalia, Manmeet
;
Ozair, Ahmad
;
Khosla, Atulya
...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v78-v78 , 2023
Link:
https://doi.org/10.1093/..
?
6
CTIM-06. A PHASE 2 STUDY OF A NOVEL IMMUNOTHERAPY SL-701 IN..:
Peereboom, David
;
Lindsay, Ross
;
Badruddoja, Michael
...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v61-v62 , 2023
Link:
https://doi.org/10.1093/..
?
7
DNAR-05. EXCEPTIONAL RESPONDERS TO BASE EXCISION REPAIR (BE..:
Ozair, Ahmad
;
Drappatz, Jan
;
Ye, Xiaobu
...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v99-v99 , 2023
Link:
https://doi.org/10.1093/..
?
8
The role of targeted therapy and immune therapy in the mana..:
Billena, Cole
;
Lobbous, Mina
;
Cordova, Christine A.
...
Frontiers in Oncology. 13 (2023) - p. , 2023
Link:
https://doi.org/10.3389/..
?
9
CTIM-26. PHASE II TRIAL OF SURVAXM PLUS TEMOZOLOMIDE FOR NE..:
Ahluwalia, Manmeet
;
Ciesielski, Michael J
;
Reardon, David A
...
Neuro-Oncology. 24 (2022) Supplement_7 - p. vii66-vii66 , 2022
Link:
https://doi.org/10.1093/..
?
10
CTIM-29. PHASE 2 STUDY OF A NOVEL IMMUNOTHERAPY SL-701 IN A..:
Peereboom, David
;
Lindsay, Ross
;
Badruddoja, Michael
...
Neuro-Oncology. 24 (2022) Supplement_7 - p. vii67-vii67 , 2022
Link:
https://doi.org/10.1093/..
?
11
CTIM-19. RANDOMIZED PHASE II OPEN-LABEL STUDY OF NIVOLUMAB ..:
Ahluwalia, Manmeet
;
Khosla, Atulya
;
Rauf, Yasmeen
...
Neuro-Oncology. 24 (2022) Supplement_7 - p. vii64-vii64 , 2022
Link:
https://doi.org/10.1093/..
?
12
CTIM-04. PHASE I STUDY OF IBRUTINIB WITH RADIATION AND TEMO..:
Ahluwalia, Manmeet
;
Patel, Neha
;
Khosla, Atulya
...
Neuro-Oncology. 24 (2022) Supplement_7 - p. vii60-vii60 , 2022
Link:
https://doi.org/10.1093/..
?
13
Quality of life following concurrent temozolomide-based che..:
Park, Deborah Y.
;
Tom, Martin C.
;
Wei, Wei
...
Journal of Neuro-Oncology. 156 (2022) 3 - p. 499-507 , 2022
Link:
https://doi.org/10.1007/..
?
14
NIMG-110. FIRST CLINICAL EXPERIENCE WITH BELZUTIFAN IN VON ..:
Dhawan, Andrew
;
Peereboom, David
;
Stevens, Glen
Neuro-Oncology. 24 (2022) Supplement_7 - p. vii191-vii191 , 2022
Link:
https://doi.org/10.1093/..
?
15
CTIM-16. PHASE 1 TRIAL OF RUXOLITINIB, TEMOZOLOMIDE, AND RA..:
Ahluwalia, Manmeet
;
Khosla, Atulya
;
Rauf, Yasmeen
...
Neuro-Oncology. 24 (2022) Supplement_7 - p. vii63-vii63 , 2022
Link:
https://doi.org/10.1093/..
1-15